UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Denali Therapeutics
DNLI
$3.88B
| $17.4M | ﹤0.01% |
852,861
+711,458
| +503% | +$18.2M |
|
2477
PUT
STMicroelectronics
STM
$47.1B
| $17.4M | ﹤0.01% |
695,900
-670,000
| -49% | -$17.8M |
|
2478
Axcelis
ACLS
$4.2B
| $17.4M | ﹤0.01% |
248,390
+112,646
| +83% | +$9.36M |
|
|
VRNA
2479
DELISTED
Verona Pharma
VRNA
| $17.3M | ﹤0.01% |
373,405
+238,837
| +177% | +$8.97M |
|
2480
First Bancorp
FBP
$4.44B
| $17.3M | ﹤0.01% |
932,695
+478,205
| +105% | +$9.65M |
|
2481
PUT
Akamai
AKAM
$17.8B
| $17.3M | ﹤0.01% |
181,100
-30,000
| -14% | -$2.94M |
|
2482
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
| $17.3M | ﹤0.01% |
412,554
-39,830
| -9% | -$1.74M |
|
2483
Tecnoglass Holdings Inc.
TGLS
$2.12B
| $17.3M | ﹤0.01% |
217,808
+188,107
| +633% | +$14.3M |
|
2484
Utz Brands
UTZ
$1.25B
| $17.3M | ﹤0.01% |
1,102,429
+522,680
| +90% | +$8.84M |
|
|
BPMC
2485
DELISTED
Blueprint Medicines
BPMC
| $17.2M | ﹤0.01% |
197,460
+79,904
| +68% | +$7.32M |
|
2486
CALL
indie Semiconductor
INDI
$716M
| $17.2M | ﹤0.01% |
+4,252,440
| New | +$17.5M |
|
2487
ADMA Biologics
ADMA
$2.15B
| $17.2M | ﹤0.01% |
1,003,932
+586,227
| +140% | +$11M |
|
2488
Birkenstock
BIRK
$6.89B
| $17.2M | ﹤0.01% |
303,610
+199,546
| +192% | +$10.1M |
|
2489
CALL
Global X Silver Miners ETF NEW
SIL
$4.5B
| $17.2M | ﹤0.01% |
541,304
+151,604
| +39% | +$5.57M |
|
2490
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $17.2M | ﹤0.01% |
392,106
+26,700
| +7% | +$1.25M |
|
2491
City Holding Co
CHCO
$2.06B
| $17.2M | ﹤0.01% |
144,765
+119,738
| +478% | +$14.8M |
|
2492
Agilysys
AGYS
$3.12B
| $17.1M | ﹤0.01% |
130,016
+106,384
| +450% | +$13M |
|
2493
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
| $17.1M | ﹤0.01% |
180,110
+1,639
| +0.9% | +$156K |
|
|
PENG
2494
Penguin Solutions Inc
PENG
$2.86B
| $17.1M | ﹤0.01% |
890,974
+602,043
| +208% | +$11M |
|
2495
VictoryShares US 500 Volatility Wtd ETF
CFA
$549M
| $17.1M | ﹤0.01% |
201,270
-36,786
| -15% | -$3.22M |
|
2496
ACM Research
ACMR
$5.52B
| $17.1M | ﹤0.01% |
1,131,565
+1,031,487
| +1,031% | +$18.6M |
|
2497
Skywest
SKYW
$4.6B
| $17.1M | ﹤0.01% |
170,528
+116,479
| +216% | +$11.9M |
|
2498
Vipshop
VIPS
$7.46B
| $17.1M | ﹤0.01% |
1,267,593
+605,023
| +91% | +$8.69M |
|
2499
Fidelity MSCI Information Technology Index ETF
FTEC
$21B
| $17.1M | ﹤0.01% |
92,306
+5,381
| +6% | +$983K |
|
2500
Stride
LRN
$3.51B
| $17M | ﹤0.01% |
164,047
+106,359
| +184% | +$10.1M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.